Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins

Atherosclerosis. 1989 Feb;75(2-3):95-104. doi: 10.1016/0021-9150(89)90165-2.

Abstract

Nineteen hypercholesterolemic patients (10 without and 9 with hypertriglyceridemia) were given evening primrose oil rich in gammalinolenic acid (GLA, 18: 3n - 6), in a placebo controlled cross-over design, over 16 weeks (8 + 8 weeks), with safflower oil as the placebo. During supplementation with evening primrose oil, dihomogammalinolenic acid (20: 3n - 6) increased in plasma lipids and red blood cells, and in subjects without hypertriglyceridemia there was a significant decrease in low density lipoprotein-cholesterol and plasma apolipoprotein B compared with the levels observed during safflower oil administration. Our results confirmed that evening primrose oil is effective in lowering low density lipoprotein in hypercholesterolemic patients.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Apolipoproteins / blood*
  • Cholesterol / blood
  • Dietary Fats, Unsaturated / pharmacology*
  • Double-Blind Method
  • Fatty Acids, Essential / pharmacology
  • Female
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / diet therapy
  • Linoleic Acids
  • Linolenic Acids / pharmacology*
  • Lipoproteins / blood*
  • Male
  • Middle Aged
  • Oenothera biennis
  • Phospholipids / blood
  • Plant Oils
  • Random Allocation
  • Safflower Oil / pharmacology
  • Triglycerides / blood
  • gamma-Linolenic Acid

Substances

  • Apolipoproteins
  • Dietary Fats, Unsaturated
  • Fatty Acids, Essential
  • Linoleic Acids
  • Linolenic Acids
  • Lipoproteins
  • Phospholipids
  • Plant Oils
  • Triglycerides
  • evening primrose oil
  • gamma-Linolenic Acid
  • Safflower Oil
  • Cholesterol